Standard Biotools | FLDM - Cash And Equivalent


Standard Biotools reported $265.77M in Cash and Equivalent for its fiscal quarter ending in March of 2026.





Cash And Equivalent Change Date
Agilent USD 1.81B 49M Mar/2026
Becton, Dickinson and Co. USD 708M 105M Jun/2026
Bio-Rad Laboratories USD 517M 9.8M Jun/2026
Bruker USD 184.9M 51.5M Jun/2026
Danaher USD 4.35B 1.35B Jun/2026
Illumina USD 1.09B 329M Mar/2026
Myriad Genetics USD 115.2M 9.2M Jun/2026
Nikon Corporation JPY 158.04B 6.7B Mar/2026
Pacific Biosciences Of California USD 61M 4.73M Jun/2026
Revvity USD 1.02B 162.62M Jun/2026
Roche Holding CHF 7.55B 579M Jun/2025
Sony JPY 2.21T 122.38B Mar/2026
Standard Biotools USD 265.77M 147.56M Mar/2026
Thermo Fisher Scientific USD 3.25B 6.6B Mar/2026
Waters USD 539M 77M Jun/2026